Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from A network medicine approach for identifying diagnostic and prognostic biomarkers and exploring drug repurposing in human cancer. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1016/j.cell.2018.02.060
10.1016/j.cell.2018.02.060 · External reference
The cancer genome atlas (TCGA): an immeasurable source of knowledge
2015 · External reference
10.1200/cci.17.00083
10.1200/cci.17.00083 · External reference
The reactome pathway knowledgebase
2020 · External reference
10.1038/nmeth.4077
10.1038/nmeth.4077 · External reference
10.1093/bioinformatics/bty247
10.1093/bioinformatics/bty247 · External reference
10.1002/ijc.33860
10.1002/ijc.33860 · External reference
10.1016/j.csbj.2021.07.007 · Admitted local publication
10.1038/s41698-017-0029-7
10.1038/s41698-017-0029-7 · External reference
A network medicine approach to build a comprehensive atlas for the prognosis of human cancer
2016 · External reference
10.1016/j.cell.2015.05.056
10.1016/j.cell.2015.05.056 · External reference
Network propagation-based prioritization of long tail genes in 17 cancer types
10.1186/s13059-021-02504-x · 2021 · External reference
Prioritizing disease genes with an improved dual label propagation framework
10.1186/s12859-018-2040-6 · 2018 · External reference
10.1371/journal.pcbi.1004120
10.1371/journal.pcbi.1004120 · External reference
Unresolved reference
External reference
10.1038/ng.3168
10.1038/ng.3168 · External reference
10.1016/j.patter.2021.100396
10.1016/j.patter.2021.100396 · External reference
10.1371/journal.pone.0162407
10.1371/journal.pone.0162407 · External reference
Individualized network-based drug repositioning infrastructure for precision oncology in the panomics era
2017 · External reference
10.1038/s41587-020-0546-8
10.1038/s41587-020-0546-8 · External reference
10.1038/ng.2653
10.1038/ng.2653 · External reference
10.1038/nbt.3519
10.1038/nbt.3519 · External reference
10.1186/1471-2105-12-323
10.1186/1471-2105-12-323 · External reference
Impact of sample size and variability on the power and Type I error rates of equivalence tests: a simulation study
2019 · External reference
10.1186/s13059-014-0550-8
10.1186/s13059-014-0550-8 · External reference
10.1186/s13059-019-1674-7
10.1186/s13059-019-1674-7 · External reference
10.1073/pnas.0506580102
10.1073/pnas.0506580102 · External reference
10.1016/j.cels.2015.12.004
10.1016/j.cels.2015.12.004 · External reference
10.1089/omi.2011.0118
10.1089/omi.2011.0118 · External reference
Genenames.org: the HGNC and VGNC resources in 2021
10.1093/nar/gkaa980 · 2021 · External reference
10.1371/journal.pcbi.1003808
10.1371/journal.pcbi.1003808 · External reference
Toward integrating feature selection algorithms for classification and clustering
10.1109/tkde.2005.66 · 2005 · External reference
Do we need hundreds of classifiers to solve real world classification problems?
2014 · External reference
10.1186/s40537-020-00327-4
10.1186/s40537-020-00327-4 · External reference
Optimal number of features as a function of sample size for various classification rules
10.1093/bioinformatics/bti171 · 2005 · External reference
10.1517/14796694.1.1.37
10.1517/14796694.1.1.37 · External reference
10.1016/j.molonc.2012.01.010
10.1016/j.molonc.2012.01.010 · External reference
10.1177/070674379504000906
10.1177/070674379504000906 · External reference
10.1186/s12864-019-6413-7
10.1186/s12864-019-6413-7 · External reference
What is an ROC curve?
10.1136/emermed-2017-206735 · 2017 · External reference
10.1023/a:1010933404324
10.1023/a:1010933404324 · External reference
Understanding survival analysis: Kaplan-Meier estimate
10.4103/0974-7788.76794 · 2010 · External reference
10.1002/(sici)1097-0258(19970228)16:4<385::aid-sim380>3.0.co;2-3
10.1002/(sici)1097-0258(19970228)16:4<385::aid-sim380>3.0.co;2-3 · External reference
10.18637/jss.v039.i05
10.18637/jss.v039.i05 · External reference
10.1007/978-1-4757-3294-8
10.1007/978-1-4757-3294-8 · External reference
10.1111/j.0006-341x.2000.00337.x
10.1111/j.0006-341x.2000.00337.x · External reference
10.1002/sim.5958
10.1002/sim.5958 · External reference
Network-based prediction of drug combinations
10.1038/s41467-019-09692-y · 2019 · External reference
10.1016/j.cell.2011.02.013
10.1016/j.cell.2011.02.013 · External reference
10.1158/2159-8290.cd-21-1059
10.1158/2159-8290.cd-21-1059 · External reference
10.1038/nrg1272
10.1038/nrg1272 · External reference
10.1038/s41467-019-08746-5
10.1038/s41467-019-08746-5 · External reference
Network- and systems-based re-engineering of dendritic cells with non-coding RNAs for cancer immunotherapy
10.7150/thno.53092 · 2020 · External reference
10.1038/nrg2634
10.1038/nrg2634 · External reference
10.1016/j.trecan.2021.01.008
10.1016/j.trecan.2021.01.008 · External reference
10.1073/pnas.94.3.952
10.1073/pnas.94.3.952 · External reference
Survival and apoptosis: a dysregulated balance in liver cancer
10.1111/j.1478-3231.2006.01409.x · 2007 · External reference
miRNA dysregulation in breast cancer
10.1158/0008-5472.can-13-1841 · 2013 · External reference
10.1038/nrc4018
10.1038/nrc4018 · External reference
Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2
10.1038/s41421-020-0153-3 · 2020 · External reference
10.1002/med.21709
10.1002/med.21709 · External reference
10.1093/bib/bbw110
10.1093/bib/bbw110 · External reference
10.1038/onc.2017.217
10.1038/onc.2017.217 · External reference
10.1038/nm1196
10.1038/nm1196 · External reference
Integrin β4 promotes cell invasion and epithelial-mesenchymal transition through the modulation of Slug expression in hepatocellular carcinoma
10.1038/srep40464 · 2017 · External reference
10.1158/0008-5472.can-10-0717
10.1158/0008-5472.can-10-0717 · External reference
10.1016/j.lungcan.2015.11.018
10.1016/j.lungcan.2015.11.018 · External reference
Loss of NOS1 expression in high-grade renal cell carcinoma associated with a shift of NO signalling
10.1038/sj.bjc.6601809 · 2004 · External reference
Effect of platelet-derived growth factor-B on renal cell carcinoma growth and progression
10.1016/j.urolonc.2014.12.015 · 2015 · External reference
10.1593/neo.08442
10.1593/neo.08442 · External reference
Targeting MET in cancer: obstacles and potentials
2015 · External reference
10.1016/j.bbcan.2012.03.002
10.1016/j.bbcan.2012.03.002 · External reference
Analysis of functional hub genes identifies CDC45 as an oncogene in non-small cell lung cancer - a short report
10.1007/s13402-019-00438-y · 2019 · External reference
10.1093/nar/gks1111
10.1093/nar/gks1111 · External reference
A web platform for the network analysis of high-throughput data in melanoma and its use to investigate mechanisms of resistance to anti-PD1 immunotherapy
10.1016/j.bbadis.2018.01.020 · 2018 · External reference
10.1038/nrg2918
10.1038/nrg2918 · External reference
10.1093/bib/bbx130
10.1093/bib/bbx130 · External reference
10.1016/j.drudis.2016.03.001
10.1016/j.drudis.2016.03.001 · External reference
10.1038/nmeth.4514
10.1038/nmeth.4514 · External reference
A large-scale benchmark of gene prioritization methods
10.1038/srep46598 · 2017 · External reference
10.1093/bioinformatics/bty148
10.1093/bioinformatics/bty148 · External reference
node2vec: scalable feature learning for networks
2016 · External reference
Benchmarking network-based gene prioritization methods for cerebral small vessel disease
10.1093/bib/bbab006 · 2021 · External reference
10.1038/nature08506
10.1038/nature08506 · External reference
Artificial intelligence, machine learning, and drug repurposing in cancer
10.1080/17460441.2021.1883585 · 2021 · External reference
Unresolved reference
External reference
Artificial intelligence in cancer target identification and drug discovery
2022 · External reference
10.1038/s41467-018-05116-5
10.1038/s41467-018-05116-5 · External reference
A review of network-based approaches to drug repositioning
10.1093/bib/bbx017 · 2018 · External reference
Network medicine framework for identifying drug-repurposing opportunities for COVID-19
2021 · External reference
10.1038/sdata.2016.18
10.1038/sdata.2016.18 · External reference
